Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

581 Press Releases
DateTitleCompany
28 Jun 11 UPS and Merck Expand Their Distribution and Logistics Agreement Merck,
Published by
Business Wire
13 Jun 11 Merck and Hanwha Chemical Corporation Establish Global Strategic Collaboration to Develop and Commercialize Biosimilar Candidate Merck,
Published by
Business Wire
09 Jun 11 Merck Serono: Patient Enrollment Completed for Cilengitide’s Pivotal Phase III Trial CENTRIC Merck Serono,
Published by
Business Wire
09 Jun 11 U.S. Prescribing Information for Simvastatin Revised to Include New Limits on the Use of the Highest Dose -- 80 mg -- and Updated Drug Interaction Information Merck,
Published by
Business Wire
08 Jun 11 Merck and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 Merck,
Published by
Business Wire
07 Jun 11 Roche and Merck Collaborate to Develop Diagnostic Tests for Merck’s Investigational Cancer Therapies Merck,
Published by
Business Wire
07 Jun 11 Merck to Present at Goldman Sachs 32nd Annual Healthcare Conference Merck,
Published by
Business Wire
06 Jun 11 Merck and ARIAD Announce Presentation of Results of Phase III SUCCEED Trial at American Society of Clinical Oncology Annual Meeting Merck,
Published by
Business Wire
06 Jun 11 ASCO 2011: Erbitux Increased Overall Survival by 5.1 Months in Patients With mCRC That Has Spread Beyond the Liver Merck Serono,
Published by
PharmiWeb.com
04 Jun 11 ASCO 2011: Erbitux Increased Overall Survival by 5.1 Months in Patients With mCRC That Has Spread Beyond the Liver Merck Serono,
Published by
Business Wire
31 May 11 Merck to Present at Sanford Bernstein 27th Strategic Decisions Conference Merck,
Published by
Business Wire
24 May 11 Merck Announces Third Quarter 2011 Dividend Merck,
Published by
Business Wire
20 May 11 CHMP Issues Positive Opinion for MSD’s 'Victrelis'® (boceprevir) Oral Hepatitis C Virus (HCV) Protease Inhibitor Merck
20 May 11 CHMP Issues Positive Opinion for Merck’s VICTRELISTM (boceprevir), Oral Hepatitis C Virus (HCV) Protease Inhibitor Merck,
Published by
Business Wire
17 May 11 Merck and Roche Establish Strategic Agreements in Fight Against Chronic Hepatitis C Merck & Co. Inc.,
Published by
Business Wire
16 May 11 Merck Completes Acquisition of Inspire Pharmaceuticals, Inc. Merck,
Published by
Business Wire
14 May 11 ADDING and REPLACING FDA Approves Merck's VICTRELIS™ (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Merck,
Published by
Business Wire
14 May 11 FDA Approves Merck's VICTRELIS™ (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Merck,
Published by
Business Wire
13 May 11 Merck Announces Successful Completion of Tender Offer for Shares of Inspire Pharmaceuticals, Inc. With Over 75 Percent of Shares Tendered Merck,
Published by
Business Wire
09 May 11 Merck Announces Hope Against Hepatitis C Initiative to Support Public Awareness, Education and Research in the Fight Against Hepatitis C Virus Merck,
Published by
Business Wire
02 May 11 Merck to Present at Deutsche Bank 36th Annual Healthcare Conference Merck,
Published by
Business Wire
29 Apr 11 Merck Announces First Quarter 2011 Financial Results Merck & Co. Inc.,
Published by
Business Wire
28 Apr 11 Merck and Inspire Announce Expiration of Hart-Scott-Rodino Act Waiting Period Relating to Tender Offer for Shares of Inspire Merck,
Published by
Business Wire
28 Apr 11 VICTRELIS™ (boceprevir) Unanimously Recommended for Approval by FDA Advisory Committee for Treatment of Chronic HCV Genotype 1 Infection Merck,
Published by
Business Wire
27 Apr 11 Merck Announces New $5 Billion Share Repurchase Program Merck,
Published by
Business Wire
25 Apr 11 Rwanda, Merck and QIAGEN Launch Africa’s First Comprehensive Cervical Cancer Prevention Program Incorporating Both HPV Vaccination and HPV Testing Merck and QIAGEN N.V.,
Published by
Business Wire
21 Apr 11 Merck and Sanofi Pasteur Initiate Phase III Study in the United States of Pediatric Combination Vaccine to Help Prevent Six Infectious Diseases Merck,
Published by
Business Wire
19 Apr 11 Publication of Survival Benefit in Leading Journal Emphasizes Importance of Erbitux in 1st Line mCRC Merck Serono,
Published by
Business Wire
15 Apr 11 Merck Commences Tender Offer for all Outstanding Shares of Inspire Pharmaceuticals, Inc. Merck,
Published by
Business Wire
15 Apr 11 Merck Reaffirms 2011 Non-GAAP EPS Target Merck,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.